Why attend?
Speakers
Plan Your Visit
Sponsors
Contact Us
Download Agenda

Temperature Controlled Logistics Europe Conference

24 - 25

March

2021

Virtual Event: 9 AM CET
Free

Why attend?

With COVID vaccines making temperature control a more important topic than ever, we’re bringing you the 2021 edition of Temperature Controlled Logistics Europe Conference to you online in the safety and comfort of your homes.

Join us for a two day event for presentations on a series of topics around temperature controlled logistics including how to avoid excursions, using data to monitor temperatures, shipping products at deep frozen temperatures and how your peers are coping with new Brexit regulations affecting the supply chain in and out of the UK.

AGENDA HIGHLIGHTS INCLUDE:

VACCINES PANEL DISCUSSION with companies including Clover Biopharmaceuticals, DHL, Seqirus and GSK
Roche presentation on direct-to-patient shipments of temperature sensitive products
Data monitoring case study from Eli Lilly and Company
BREXIT: An open discussion session on adapting to new regulations
Roundtable on supply chain digitalization from Sagent Pharmaceuticals
New technology in temperature controlled logistics: a panel discussion including speakers from Novapeutics, Merck, the Center for Supply Chain Innovation and Berlinger

Agenda

Expand All

Speakers

Select a speaker to learn more

Back

Kaio Kikuchi

Senior Manager Cold Chain, Zoetis

Next speaker

Back

Frank Leu

CEO, Novapeutics,

Frank Leu is a Co-Founder and CEO of Novapeutics at Philadelphia, PA - a biopharma spun-out from the University of Pennsylvania, developing a first-in-class small molecule beta-cell restoration curative for type 2 diabetes. Prior, Frank was at a specialty pharma Verto Institute, developing biologic therapeutics for treating the neuroendocrine cancer. Frank graduated with a Pharmacology Ph.D. from Weill Cornell Graduate School of Medical Sciences in 2001, and then post-doc in a Howard Hughes Medical Institute laboratory at the Rockefeller University in molecular enzymology. He has served as an adjunct instructor at the Rutgers Cancer Institute of NJ, and is an adjunct professor at the pharmacology department of the Thomas Jefferson Medical University. Frank also founded BioPharMatrix developing blockchain solutions to lifescience innovations at all phases, and serves as advisor to the Pennovations center working with 1776 / Benjamins Desk. Frank is a thought leader in the blockchain architecture innovations in the life-sciences and drug development, Frank serves on multiple advisory boards and frequently served as chairman, speaker, moderator, and facilitator for many life-sciences and drug development events.

Next speaker

Back

Dave Malenfant

Executive Vice-President, Industry Liaison | Director, Center For Supply Chain Innovation, BSMA (Biotech Supply Management Alliance) | Neeley School Of Business, TCU (Texas Christian University)

Dave is recognized for the creative development of standardized systems and business processes, and for developing enabling technology throughout the entire supply chain. During his career, Dave has implemented over 30 different computer systems – WMS, ERP, Finite Scheduling, Product Launch, and Order Entry, among others. Dave is past Chairman of the Supply Chain Council and past member of the Executive Committee of NASSTRAC. Dave is currently Executive Vice President of Industry Liaison and Talent Development for the BSMA (Biotech Supply Management Alliance). In 1993, Dave joined Alcon Laboratories where he steadily advanced through leadership roles such as Purchasing Manager, Materials Operation Manager, and Global Supply Chain Director before becoming the Vice President of Global Supply Chain in 2005. In this role, Dave provided strategic direction for the company’s Global Supply Chain initiatives and created global centers of excellence for Purchasing, Distribution, Transportation, Customer Service, Sales and Operations Management, Data Management, Graphic Design and Artwork Development, and Product Launches. Dave retired from Alcon in 2014.

Next speaker

Back

STEFAN DÜRR

Senior Director, Client Delivery /Head Of Drug Supply Center Of Excellence, Cenduit

Senior Director, Client Delivery at Cenduit IRT, an IQVIA business, Head of Drug Supply Center of Excellence

Stefan has worked in IRT for 15 years and has been with Cenduit IRT, an IQVIA business, since its inception in 2007. He has worked in various project management roles including leading the global project management team at Cenduit. Stefan currently is responsible for client delivery of key customer accounts and heads the Cenduit drug supply center of excellence. He is very passionate about finding innovative solutions for clinical supply challenges.

Stefan holds a master of science in molecular biology and an international executive MBA of the University of St. Gallen.

Next speaker

Back

Harald van Weeren

Segment Manager Clinical Trials, Head of Segment Management, Berlinger & Co. AG

Harald van Weeren is the Segment Manager for Clinical Trials and the Head of Segment Management at Berlinger & Co. AG. Harald holds a PhD in Physics from the University of Twente, The Netherlands. With over 15 years of experience in Product Management and Market Segment Management across various high-tech industries, Harald joined Berlinger in 2020. In his role, he is responsible for directing Berlinger's focus on Clinical Trials, tracking market trends, and ensuring cutting-edge condition monitoring solutions for clinical trial supply.

Next speaker